Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
Active, not recruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
May 30, 2023
Primary Completion Date
August 14, 2024
Study Completion Date
July 22, 2025
Conditions
Idiopathic Pulmonary Arterial Hypertension
Trial Locations (1)
121552
Russian National Cardilogy Reasearch Center, Moscow
All Listed Sponsors
lead
Russian Cardiology Research and Production Center
OTHER
NCT06587074 - Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy | Biotech Hunter | Biotech Hunter